SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-18-013527
Filing Date
2018-07-20
Accepted
2018-07-19 20:45:16
Documents
1
Effectiveness Date
2018-07-20

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A navb20180719_defa14a.htm DEFA14A 66160
  Complete submission text file 0001437749-18-013527.txt   67287
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35076 | Film No.: 18961346
SIC: 2835 In Vitro & In Vivo Diagnostic Substances